KFSH’s integrated framework connects medical genomics, an internationally accredited precision medicine laboratory, computational sciences, and translational research, creating a system where ...
L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2025, en ce compris la distribution d’un dividende brut de € 1 ...
The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a gross dividend of € 1.08 per share. The dividend will be paya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results